A New Review Stresses that Non-Vitamin K Antagonist Oral Anticoagulants Can Reduce Atrial Fibrillation-Related Stroke With Significantly Reduced Cardiovascular and Bleeding Risks Compared With Warfarin
LONDON, June 9, 2016 (PRNewswire) European Neurological Review, the peer-reviewed journal, has published a review that explores the improved patient outcomes resulting from atrial fibrillation (AF) prevention.